¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ +O3ze L  
=If% m9  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© : N ^1T6v  
+V1EqC*  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 8rXq-V_u  
C. s{ &  
1.Co-stimulators (or co-stimulating molecules) wNDLN`,^H  
aGNVqS%y  
2.NK-kB /7*jH2  
F1R91V|  
3.Immunoglobulin superfamily 2.}<VivT  
QRdNi 1&M  
4.antigen-presenting cell (APC) !^!<Xz ;  
>1a- }>r  
5.death domain $/],QD_;"  
4 C[,S|J  
6.CCR and CXCR UA{sUj+?  
!$AVl MnJ  
7.Lectin (or mitogen) \^;Gv%E  
]l+Bg;F#V  
8.Clusters of differentiation, CD) NmST1pMk  
Y_>z"T  
9.B7 family 51.F,uY  
riZFcVsB  
10.Cytotoxic T lymphocyte, CTL) 52m^jT Sx  
qh0)~JL4   
11.IL-15 and IL-15 receptor (IL-15R) )&+_T+\  
nen6!bw4  
12.MHC restriction % 2BFbaE  
N ED`GU  
13.Affinity-chromatography I.R3?+tZ  
^K@r!)We  
14.Cyctosprin A, CsA vc6UA%/f  
?*}76u  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) \*LMc69  
|rdG+ >  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Lj*F KP\{  
KblOP{I  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ><LIOFqsS  
)FWF T:P~  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ qqw6p j  
ZhxMA*fL  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ UgJlXB|a%2  
ejgg.G ^  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© kUP[&/Lc  
[2i+f <  
ÃâÒßѧרҵ£º G8u8&|  
Y D.3FTNGC  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ x ?^c:`.  
^{6Y7T]  
Ïû»¯ÄÚ¿Æ£º 0 p2 0Rt  
{)b`fq  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ OzO_E8Kb\  
d[~c-G6  
ѪҺ²¡Ñ§×¨Òµ£º E*(Q'p9C  
K"}Dbr  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
2+6=? ÕýÈ·´ð°¸:8
°´"Ctrl+Enter"Ö±½ÓÌá½»